NYXH

Nyxoah SA

Price Chart

No historical data available

Latest Quote

$1.56

-0.04 (-2.50%)

Current Price

Previous Close	$1.60
Open	$1.62
Day High	$1.62
Day Low	$1.55
Volume	105,890

Fetched: 2026-08-31T20:35:27

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	101.84M
Total Debt	$69.70M
Cash Equivalents	$113.61M
Revenue	$25.17M
Net Income	$-111.54M
Sector	Healthcare
Industry	Medical Instruments & Supplies
Market Cap	$158.87M
EPS (TTM)	$-2.55
Exchange	NGM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Nyxoah SA

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

📰 Latest News

No news articles available at the moment. Check back later for updates on NYXH.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$620,425	$137,098	$392,704	$153,364
Cost Of Revenue	$4,291,855	$1,803,183	$1,924,015	$1,336,122
Total Revenue	$11,641,687	$5,252,701	$5,051,702	$3,583,130
Operating Revenue	$11,641,687	$5,252,701	$5,051,702	$3,583,130
Expenses
Interest Expense	$2,147,090	$1,029,395	$252,120	$275,357
Total Expenses	$108,007,435	$73,579,644	$57,453,235	$41,341,931
Rent Expense Supplemental	$572,790	$742,419	$368,305	$511,212
Other Income Expense	$-2,229,581	$2,065,760	$-1,074,707	$3,350,761
Net Non Operating Interest Income Expense	$-4,900,662	$695,945	$1,591,728	$-512,374
Total Other Finance Cost	$4,884,396	$1,181,596	$1,143,255	$669,223
Interest Expense Non Operating	$2,147,090	$1,029,395	$252,120	$275,357
Operating Expense	$103,715,579	$71,776,460	$55,529,220	$40,005,809
Other Operating Expenses	$-1,530,150	$-1,171,140	$-632,044	$-328,802
General And Administrative Expense	$53,952,596	$31,575,462	$23,986,290	$20,844,661
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Net Interest Income	$-4,900,662	$695,945	$1,591,728	$-512,374
Interest Income	$2,130,824	$2,906,936	$2,987,103	$432,206
Normalized Income	$-102,992,621	$-70,372,371	$-49,165,715	$-38,791,681
Net Income From Continuing And Discontinued Operation	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Total Operating Income As Reported	$-96,996,630	$-68,326,943	$-52,401,533	$-37,758,801
Net Income Common Stockholders	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Net Income	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Net Income Including Noncontrolling Interests	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Net Income Continuous Operations	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Pretax Income	$-103,492,505	$-65,565,237	$-51,884,512	$-34,920,413
Special Income Charges	$-634,367	$0	$0	-
Interest Income Non Operating	$2,130,824	$2,906,936	$2,987,103	$432,206
Operating Income	$-96,365,748	$-68,326,943	$-52,401,533	$-37,758,801
Depreciation Amortization Depletion Income Statement	$1,538,283	$1,491,809	$1,210,642	$1,061,926
Depreciation And Amortization In Income Statement	$1,538,283	$1,491,809	$1,210,642	$1,061,926
Gross Profit	$7,349,831	$3,449,518	$3,127,687	$2,247,008
Per Share
Diluted EPS	$-2.75	$-2.10	$-1.80	$-1.40
Basic EPS	$-2.75	$-2.10	$-1.80	$-1.40
Other
Tax Effect Of Unusual Items	$-557,395	$516,440	$-34,775	$837,690
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-93,906,122	$-63,443,708	$-47,815,731	$-35,751,132
Total Unusual Items	$-2,229,581	$2,065,760	$-1,074,707	$3,350,761
Total Unusual Items Excluding Goodwill	$-2,229,581	$2,065,760	$-1,074,707	$3,350,761
Reconciled Depreciation	$5,209,713	$3,157,895	$2,741,954	$2,244,685
EBITDA (Bullshit earnings)	$-96,135,703	$-61,377,948	$-48,890,438	$-32,400,372
EBIT	$-101,345,416	$-64,535,842	$-51,632,392	$-34,645,056
Diluted Average Shares	$44,274,453	$38,044,804	$32,494,646	$30,007,122
Basic Average Shares	$44,274,453	$38,044,804	$32,494,646	$30,007,122
Diluted NI Availto Com Stockholders	$-104,664,807	$-68,823,050	$-50,205,646	$-36,278,610
Tax Provision	$1,172,302	$3,257,813	$-1,678,866	$1,358,197
Gain On Sale Of Ppe	$-188,219	$0	$0	-
Other Special Charges	$-138,260	-	-	-
Write Off	$584,408	$0	$0	-
Gain On Sale Of Security	$-1,595,213	$2,065,760	$-1,074,707	$3,350,761
Research And Development	$49,754,850	$39,880,330	$30,964,331	$18,428,024
Selling General And Administration	$53,952,596	$31,575,462	$23,986,290	$20,844,661
Other Gand A	$22,274,892	$16,987,336	$12,080,864	$9,226,211
Insurance And Claims	$500,755	$593,703	$1,144,417	$1,747,415
Rent And Landing Fees	$572,790	$742,419	$368,305	$511,212
Salaries And Wages	$30,604,159	$13,252,004	$10,392,704	$9,359,823

Fetched: 2026-08-31

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$-1,137,446	$73,048,681	$59,735,099	$93,356,569
Total Assets	$137,644,939	$184,043,219	$144,251,190	$169,711,861
Total Non Current Assets	$66,524,921	$70,085,976	$64,837,922	$53,225,281
Non Current Deferred Assets	$101,081	$88,300	$65,063	$54,607
Non Current Deferred Taxes Assets	$101,081	$88,300	$65,063	$54,607
Non Current Accounts Receivable	$1,890,322	$1,748,577	$1,354,711	$200,999
Financial Assets	$105,728	$130,127	-	-
Goodwill And Other Intangible Assets	$58,217,729	$58,534,913	$54,151,272	$46,441,268
Other Intangible Assets	$58,217,729	$58,534,913	$54,151,272	$46,441,268
Current Assets	$71,120,018	$113,957,243	$79,413,268	$116,486,580
Hedging Assets Current	$4,647	$0	$398,513	$1,162
Current Deferred Assets	$770,303	$1,066,574	-	-
Prepaid Assets	$356,686	$852,794	-	-
Inventory	$5,414,198	$5,479,261	$3,851,516	$1,024,747
Receivables	$8,804,461	$7,156,965	$6,537,702	$3,760,892
Other Receivables	$1,044,499	$1,243,174	$1,406,994	$892,297
Taxes Receivable	$1,655,629	$1,984,431	$1,926,339	$1,168,816
Accounts Receivable	$6,104,334	$3,929,360	$3,204,369	$1,699,779
Cash Cash Equivalents And Short Term Investments	$55,769,722	$99,401,649	$67,094,225	$110,207,969
Cash And Cash Equivalents	$34,856,512	$39,718,833	$25,107,470	$20,783,083
Cash Equivalents	$25,712,792	$32,787,266	$10,640,177	$41,826
Cash Financial	$9,143,720	$6,931,567	$14,467,294	$20,741,257
Other Current Assets	-	$1,924,015	$1,531,312	$1,491,809
Debt
Net Debt	$10,523,992	-	-	-
Total Debt	$47,025,676	$26,319,275	$14,760,079	$13,806,204
Long Term Debt And Capital Lease Obligation	$19,409,783	$24,732,195	$13,348,437	$12,518,880
Long Term Debt	$18,669,687	$21,755,548	$9,728,128	$9,514,349
Current Debt And Capital Lease Obligation	$27,615,894	$1,587,080	$1,411,642	$1,287,324
Current Debt	$26,710,817	$288,138	$422,912	$451,958
Other Current Borrowings	$26,710,817	$288,138	$422,912	$451,958
Liabilities
Total Liabilities Net Minority Interest	$80,564,656	$52,459,625	$30,364,819	$29,914,023
Total Non Current Liabilities Net Minority Interest	$23,683,048	$27,446,264	$13,584,292	$12,587,429
Derivative Product Liabilities	$1,860,114	-	-	-
Non Current Deferred Liabilities	$791,216	$570,466	$10,457	$0
Non Current Deferred Taxes Liabilities	$0	$22,075	$10,457	$0
Current Liabilities	$56,881,608	$25,013,361	$16,780,527	$17,326,594
Other Current Liabilities	$1,753,224	$1,691,646	$336,935	$10,457
Current Deferred Liabilities	$1,038,689	$135,936	$0	-
Payables And Accrued Expenses	$25,832,462	$20,549,553	$14,112,931	$15,317,764
Payables	$10,866,736	$9,371,442	$7,075,636	$6,573,719
Total Tax Payable	$4,862,321	$5,015,685	$2,309,748	$4,245,382
Accounts Payable	$6,004,415	$4,355,757	$4,765,888	$2,176,136
Other Non Current Liabilities	-	$981,759	-	$1,162
Other Payable	-	-	$232,369	$152,202
Equity
Common Stock Equity	$57,080,283	$131,583,594	$113,886,371	$139,797,838
Total Equity Gross Minority Interest	$57,080,283	$131,583,594	$113,886,371	$139,797,838
Stockholders Equity	$57,080,283	$131,583,594	$113,886,371	$139,797,838
Other Equity Interest	$14,401,069	$10,805,158	$8,900,895	$6,558,615
Gains Losses Not Affecting Retained Earnings	$1,305,914	$1,061,926	$159,173	$204,485
Other Equity Adjustments	$1,305,914	$1,061,926	$159,173	$204,485
Retained Earnings	$-355,558,264	$-252,974,321	$-186,858,370	$-137,344,021
Other
Ordinary Shares Number	$49,990,077	$43,484,681	$33,314,726	$30,029,370
Share Issued	$49,990,077	$43,484,681	$33,314,726	$30,029,370
Tangible Book Value	$-1,137,446	$73,048,681	$59,735,099	$93,356,569
Invested Capital	$102,460,787	$153,627,279	$124,037,410	$149,764,144
Working Capital	$14,238,410	$88,943,882	$62,632,740	$99,159,985
Capital Lease Obligations	$1,645,173	$4,275,590	$4,609,039	$3,839,898
Total Capitalization	$75,749,970	$153,339,141	$123,614,499	$149,312,186
Additional Paid In Capital	$389,373,762	$365,220,167	$285,961,424	$265,220,167
Capital Stock	$7,557,802	$7,470,663	$5,723,248	$5,158,592
Common Stock	$7,557,802	$7,470,663	$5,723,248	$5,158,592
Non Current Deferred Revenue	$791,216	$548,391	$0	-
Long Term Capital Lease Obligation	$740,095	$2,976,647	$3,620,309	$3,004,531
Long Term Provisions	$1,621,936	$1,161,845	$214,941	$68,549
Current Deferred Revenue	$1,038,689	$135,936	$0	-
Current Capital Lease Obligation	$905,077	$1,298,943	$988,730	$835,367
Pensionand Other Post Retirement Benefit Plans Current	$641,338	$1,049,146	$919,019	$711,049
Current Accrued Expenses	$14,965,725	$11,178,111	$7,037,295	$8,744,045
Net PPE	$6,210,062	$9,584,059	$9,266,876	$6,528,407
Accumulated Depreciation	$-5,740,676	$-6,609,736	$-4,720,576	$-3,213,663
Gross PPE	$11,950,738	$16,193,796	$13,987,452	$9,742,070
Leases	$4,782,154	$2,133,147	$1,526,664	$817,939
Construction In Progress	$34,855	$2,624,608	$2,387,591	$834,205
Other Properties	$2,072,731	$2,209,829	$1,743,929	$1,452,306
Machinery Furniture Equipment	$3,085,860	$3,349,599	$2,980,132	$2,427,094
Buildings And Improvements	$1,975,136	$5,876,612	$5,349,134	$4,210,526
Properties	$0	$0	$0	$0
Finished Goods	$1,735,796	$1,266,411	$529,801	$329,964
Work In Process	$2,150,575	$2,958,057	$1,777,623	$116,184
Raw Materials	$1,527,826	$1,254,793	$1,544,092	$578,599
Other Short Term Investments	$20,913,210	$59,682,816	$41,986,755	$89,424,886
Employee Benefits	-	$0	$10,457	$0
Non Current Pension And Other Postretirement Benefit Plans	-	$0	$10,457	$0
Preferred Stock	-	-	-	$0

Fetched: 2026-08-31

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-84,521,900	$-64,247,705	$-64,761,240	$-52,405,019
Operating Activities
Operating Cash Flow	$-80,142,906	$-57,192,982	$-52,025,095	$-33,410,015
Cash Flow From Continuing Operating Activities	$-80,142,906	$-57,192,982	$-52,025,095	$-33,410,015
Operating Gains Losses	$1,783,432	$-2,065,760	$1,074,707	$-3,350,761
Investing Activities
Capital Expenditure	$-4,378,994	$-7,054,723	$-12,736,145	$-18,995,004
Investing Cash Flow	$32,917,393	$-18,967,120	$37,191,820	$-104,503,310
Cash Flow From Continuing Investing Activities	$32,917,393	$-18,967,120	$37,191,820	$-104,503,310
Capital Expenditure Reported	$-3,443,709	$-5,701,173	$-9,831,532	$-17,965,609
Financing Activities
Issuance Of Capital Stock	$24,240,734	$81,006,157	$21,304,752	$296,270
Financing Cash Flow	$44,274,427	$89,972,115	$19,586,383	$-1,142,094
Cash Flow From Continuing Financing Activities	$44,274,427	$89,972,115	$19,586,383	$-1,142,094
Net Other Financing Charges	$-3,777,158	$-304,403	$-59,254	$-42,988
Cash Dividends Paid	$0	$0	$0	$0
Net Common Stock Issuance	$24,240,734	$81,006,157	$21,304,752	$296,270
Common Stock Issuance	$24,240,734	$81,006,157	$21,304,752	$296,270
Other
Repayment Of Debt	$-1,524,341	$-1,771,814	$-1,436,040	$-1,244,336
Issuance Of Debt	$26,141,512	$11,618,450	$0	$0
End Cash Position	$34,856,512	$39,718,833	$25,107,470	$20,783,083
Beginning Cash Position	$39,718,833	$25,107,470	$20,783,083	$157,440,454
Effect Of Exchange Rate Changes	$-1,911,235	$799,349	$-428,721	$2,398,048
Changes In Cash	$-2,951,086	$13,812,013	$4,753,108	$-139,055,419
Interest Paid Cff	$-806,320	$-576,275	$-223,074	$-151,040
Net Issuance Payments Of Debt	$24,617,172	$9,846,636	$-1,436,040	$-1,244,336
Net Long Term Debt Issuance	$24,617,172	$9,846,636	$-1,436,040	$-1,244,336
Long Term Debt Payments	$-1,524,341	$-1,771,814	$-1,436,040	$-1,244,336
Long Term Debt Issuance	$26,141,512	$11,618,450	$0	$0
Interest Received Cfi	$2,500,290	$2,624,608	$2,683,862	$127,803
Net Investment Purchase And Sale	$34,792,610	$-14,545,138	$47,244,103	$-85,636,109
Sale Of Investment	$83,648,193	$99,119,321	$140,212,616	$33,592,424
Purchase Of Investment	$-48,855,582	$-113,664,458	$-92,968,513	$-119,228,534
Net PPE Purchase And Sale	$-931,800	$-1,345,417	$-2,904,612	$-1,029,395
Sale Of PPE	$3,486	$8,133	$0	$0
Purchase Of PPE	$-935,285	$-1,353,549	$-2,904,612	$-1,029,395
Taxes Refund Paid	$-1,211,804	$-621,587	$-916,696	$-476,356
Change In Working Capital	$6,240,269	$3,441,385	$-4,059,486	$99,919
Change In Payables And Accrued Expense	$8,661,554	$5,941,675	$556,524	$714,535
Change In Payable	$8,661,554	$5,941,675	$556,524	$714,535
Change In Inventory	$65,063	$-1,627,745	$-2,826,769	$-622,749
Change In Receivables	$-2,486,348	$-872,546	$-1,789,241	$8,133
Other Non Cash Items	$3,202,045	$-1,099,105	$-2,265,598	$-188,219
Stock Based Compensation	$5,676,775	$4,610,201	$3,033,577	$3,134,658
Unrealized Gain Loss On Investment Securities	$59,254	$0	$0	-
Provisionand Write Offof Assets	$438,016	$949,227	$250,959	$42,988
Asset Impairment Charge	$1,951,900	$0	$0	-
Depreciation Amortization Depletion	$5,209,713	$3,157,895	$2,741,954	$2,244,685
Depreciation And Amortization	$5,209,713	$3,157,895	$2,741,954	$2,244,685
Amortization Cash Flow	$2,590,914	$1,122,342	$1,117,695	$944,580
Amortization Of Intangibles	$2,590,914	$1,122,342	$1,117,695	$944,580
Depreciation	$2,618,799	$2,035,552	$1,624,259	$1,300,105
Gain Loss On Investment Securities	$-1,842,686	$468,224	$-293,947	$3,160,218
Net Foreign Currency Exchange Gain Loss	$3,437,899	$-2,533,984	$1,368,653	$-6,510,979
Gain Loss On Sale Of PPE	$188,219	$0	$0	-
Net Income From Continuing Operations	$-103,492,505	$-65,565,237	$-51,884,512	$-34,920,413
Interest Received Cfo	-	$0	$0	$3,486

Fetched: 2026-08-31